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The disease of arterial aneurysms is now well
documented. An analysis of the established abdomi-
nal aneurysmal tissue has shown that the aortic wall
is characterized by a derangement of the extracellu-
lar matrix with a reduction in elastin concentra-
tion.1-4 These structural changes within the aorta are
associated with increased levels of matrix metallo-
proteinases,5-8 a diffuse white cell infiltrate,9,10 and
the expression of auto-antigenic proteins in the aor-
tic adventitia.11,12 However, despite the extensive
characterization of the abnormalities within the aor-
tic wall, the cause of arterial aneurysms remains
undefined.
This failure to elucidate the initiating factors in
aneurysmal disease reflects the emphasis of previous
research on the characterization of the pathophysiol-
ogy of established aneurysmal tissue. Unfortunately,
the analysis of the tissue at the end of a disease
process will not differentiate causal factors from
degenerative effects. To overcome these difficulties,
a source of tissue at the beginning of the aneurysmal
process is necessary, but this tissue has been practi-
cally impossible to obtain.
Despite the difficulties in determining the cause
of abdominal aneurysms, several investigators have
suggested that the patients with arterial aneurysms
have a systemic disease.13 Ward14 observed that the
mean diameters for all the peripheral arteries were
significantly greater in the patients with aortic
aneurysms than in the control groups, and Baxter et
al15 demonstrated that the extracellular matrix
abnormalities that were present in the aneurysmal
wall were also identifiable in the aortic tissue proxi-
mal to the aneurysmal site. Both of these studies
suggested that localized aneurysmal disease may be
a manifestation of a systemic dilating process.
True aneurysms may affect virtually any part of
the circulation, and several contemporary reports
have observed that aneurysmal dilatation may compli-
cate both coronary and infrainguinal vein grafts.16-20
The aim of the present study was to determine the
prevalence of true infrainguinal vein graft aneurysms
Prevalence of true vein graft aneurysms:
Implications for aneurysm pathogenesis
Ian M. Loftus, BSc, FRCS, Mark J. McCarthy, FRCS, Andrew Lloyd, DPhil,
A. Ross Naylor, MD, FRCS, Peter R. F. Bell, MD, FRCS, and Matthew M.
Thompson, MD, FRCS, Leicester, United Kingdom
Background: Circumstantial evidence suggests that arterial aneurysms have a different
cause than atherosclerosis and may form part of a generalized dilating diathesis. The aim
of this study was to compare the rates of spontaneous aneurysm formation in vein grafts
performed either for popliteal aneurysms or for occlusive disease. The hypothesis was
that if arterial aneurysms form a part of a systemic process, then the rates of vein graft
aneurysms should be higher for patients with popliteal aneurysms than for patients with
lower limb ischemia caused by atherosclerosis.
Methods: Infrainguinal vein grafting procedures performed from 1990 to 1995 were
entered into a prospective audit and graft surveillance program. Aneurysmal change was
defined as a focal increase in the graft diameter of 1.5 cm or greater, excluding false
aneurysms and dilatations after graft angioplasty. 
Results: During the study period, 221 grafting procedures were performed in 200
patients with occlusive disease and 24 grafting procedures were performed in 21 patients
with popliteal aneurysms. Graft surveillance revealed spontaneous aneurysm formation
in 10 of the 24 bypass grafts (42%) for popliteal aneurysms but in only 4 of the 221
grafting procedures (2%) that were performed for chronic lower limb ischemia.
Conclusion: This study provides further evidence that aneurysmal disease is a systemic
process, and this finding has clinical implications for the treatment of popliteal
aneurysms. (J Vasc Surg 1999;29:403-8.)
403
From the Department of Surgery, University of Leicester.
Reprint requests: M. M. Thompson, MD, FRCS, Department of
Surgery, Clinical Sciences Building, Leicester LE2 7LX, United
Kingdom.
Copyright © 1999 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/1/93323
in two groups of patients—those who underwent
bypass grafting for chronic lower limb ischemia as a
result of atherosclerotic occlusive disease and those
who underwent bypass grafting and ligation of a
popliteal aneurysm. The hypothesis of the investiga-
tion was that if the arterial aneurysms were a part of
a systemic dilating disease, then the prevalence of
true vein graft aneurysms should be higher for the
patients with popliteal aneurysms.
METHODS
Patients. All patients who underwent infra-
genicular bypass grafting for lower limb arterial
occlusive disease or for popliteal aneurysm between
January 1990 and December 1995 were entered
into the study. The demographic data, the vascular
risk factors, and the clinical findings were prospec-
tively recorded. The technique used in our center of
femoropopliteal-crural bypass grafting for patients
with occlusive disease has been described previous-
ly.21-23 Our operative strategy for the treatment of
elective popliteal aneurysms involved a medial
approach with a long saphenous vein bypass graft
from the superficial femoral artery to the most prox-
imal patent run-off vessel, which was combined with
proximal and distal aneurysm ligation. No patient in
the study underwent a posterior approach with inlay
grafting.
Surveillance. After surgery, all the patent vein
grafts were entered into a graft surveillance program
as previously described.24,25 Duplex scans were per-
formed at 1, 3, 6, and 12 months after surgery and
then every 6 months thereafter. All the data were
entered into a computerized audit database. True
vein graft aneurysm formation was defined as a focal
increase in the graft diameter in excess of 1.5 cm.
Aneurysm formation after transluminal or patch
angioplasty was classified as false, rather than true.
Statistical analysis. The prevalence of true vein
graft aneurysm formation in patients who under-
went bypass grafting for occlusive disease or for
popliteal aneurysm was calculated with life-table
analysis. The differences between the two groups
were compared by means of Kaplan-Meier method
and with the c 2 test. Multiple logistic regression
analysis was performed to establish the role of the
independent risk factors in vein graft aneurysm for-
mation. For the comparison of the demographic fac-
tors between the two patient groups, the Mann-
Whitney test for continuous variables and the c 2 test
for discrete variables were used.
RESULTS
During the study period, a total of 245 infrain-
guinal vein grafting procedures were performed in
221 patients. In 200 patients, 221 grafting proce-
dures were performed for arterial occlusive disease,
and in 21 patients, 24 procedures were performed
for bypass grafting of popliteal aneurysms. The
demographic data and the individual vascular risk
factors for these two groups of patients are tabulat-
ed in Table I. None of the demographic factors were
significantly different between the two patient
groups (Mann-Whitney and c 2 tests).
The median follow-up period for the patients
with occlusive disease was 19 months (range, 1 to 91
months) as compared with 24 months (range, 1 to
84 months) for the group with popliteal aneurysms
(P > .05, Mann-Whitney test). Overall, the preva-
lence of true vein graft aneurysms for the patients
with occlusive arterial disease was 4 from a total of
221 grafts (1.8%). Correspondingly, the prevalence
of graft aneurysms in those bypass grafting proce-
dures for popliteal aneurysms was 10 of the 24 grafts
(41.6.%). This difference was highly significant (P <
.001, Kaplan-Meier method), as shown by the life-
table analysis illustrated in Fig 1.
Of those aneurysms that were detected in the
vein grafting procedures for popliteal aneurysms,
three were in the proximal third of the graft, one was
found at mid graft, and four were within the distal
third. The remaining three aneurysms exhibited
multiple aneurysmal areas throughout the graft. In
the occlusive group, two of the vein graft aneurysms
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Fig 1. Cumulative 5-year life-table analysis shows the
proportion of vein grafts without true aneurysm forma-
tion at 12 monthly intervals. Figures in the table represent
total number of grafts under surveillance for up to 6 years.
were in the proximal third, one was at mid graft, and
one was in the distal third.
The aneurysms that were detected in those graft-
ing procedures for occlusive disease were detected
marginally earlier (median, 18 months; range, 6 to
48 months) than those procedures for popliteal
aneurysms (median, 24 months; range, 6 to 84
months), although this difference was not signifi-
cant. Six of the aneurysms that were detected in the
bypass grafts for popliteal aneurysms were larger
than 2 cm, and only one of the aneurysms that were
detected in the occlusive group reached this size.
There was no difference in the follow-up period
between the group of patients with vein graft
aneurysms as compared with the group without. 
Multiple logistic regression analysis was per-
formed to evaluate the contribution of each of the
individual vascular risk factors to the development of
true vein graft aneurysms. Only one factor, the pres-
ence of a popliteal aneurysm, had a significant effect
on the development of vein graft aneurysms, with a
relative risk of vein graft aneurysm formation in
patients with popliteal aneurysms of 22.7 times that
of patients with occlusive disease.
To date, three patients with true vein graft
aneurysms have undergone segmental surgical revi-
sion (Fig 2). All three patients had their original
operation for popliteal aneurysm and had vein graft
dilatation in excess of 3 cm. None of these patients
were seen with acute complications, and none of the
procedures were revised on the basis of the scan
results. All the other aneurysms continued in the
surveillance program. Four of the patients with
popliteal aneurysms had aortic aneurysms of greater
than 4 cm in diameter—two patients in the group
had true vein graft aneurysm, and three have been
repaired to date. The graft type and the anastomosis
sites for the group with popliteal aneurysms are
shown in Table III.
DISCUSSION
The existence of aneurysms that complicate vein
grafts is relatively well documented.20,26 Szilagyi et
al27 reported aneurysmal degeneration in 4% of the
infrainguinal vein grafts, whereas coronary and renal
grafts appear to be similarly affected.20 The present
study has revealed similar findings for the develop-
ment of aneurysmal changes in 1.8% of the infrain-
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Table I. Demographic data and incidence rates of individual risk factors in the group of 200 patients with
occlusive disease and in the 21 patients with popliteal aneurysms
Occlusive disease Aneurysmal disease P value
Median age (years) 72 (range, 31 to 97) 67 (range, 40 to 85) .18
Sex (% male) 68 90 .47
IHD (%) 22 24 .82
CVD (%) 14 24 .59
Smoking (%) 77 85 .71
Hypertension (%) 35 24 .95
Diabetes (%) 31 15 .61
IHD, Ischemic heart disease; CVD, cerebrovascular disease.
Statistical analysis was performed with the Mann-Whitney and c 2 tests.
Table II. Life-table analysis
No. patients No. grafts No. of graft Interval Cumulative proportion of vein
Interval
entering this withdrawn during aneurysms aneurysm grafts without aneurysm Standard
(months)
interval this interval detected detection rate at end of interval error
A B A B A B A B A B A B
0 to 12 221 24 108 5 0 1 0.000 0.046 100 95.3 0.00 4.54
12 to 24 113 18 27 2 2 2 0.020 0.118 98.0 84.1 1.41 8.46
24 to 36 84 14 29 3 1 2 0.014 0.160 96.6 70.7 1.97 11.2
36 to 48 54 9 9 1 0 3 0.000 0.353 96.6 45.7 1.97 13.7
48 to 60 30 5 13 1 1 1 0.039 0.222 92.8 35.6 4.17 13.9
60 to 72 20 3 5 2 0 0 0.000 0.000 92.8 35.6 4.17 13.9
72 to 84 7 1 5 0 0 0 0.000 0.000 92.8 35.6 4.17 13.9
A, Column A represents patients with occlusive disease; B, column B represents patients with popliteal aneurysms.
guinal grafting procedures that were performed for
occlusive disease.
The cause of vein graft aneurysms has not received
a great deal of attention presumably because of their
rarity. Several authors have suggested that vein graft
aneurysms may be associated with arterial aneurysms
elsewhere,28-30 and Alexander and Liu18 suggested
that these aneurysms developed as a result of athero-
sclerosis. The present study has shown conclusively
that the only factor significantly associated with the
development of vein graft aneurysms is the presence of
a popliteal aneurysm with a relative risk of 23. These
data strongly support the observations of Tilson31
who suggested that the patients with vein graft
aneurysms have a systemic dilating diathesis that may
affect the veins and the arteries. This observation may
have important clinical and scientific implications.
Previous series that reported the results of
surgery for popliteal aneurysm have not shown a
high incidence rate of vein graft aneurysms,32-34
which may reflect the time to develop graft dilata-
tion (median, 24 months) or the intensive graft sur-
veillance protocol used in this study. One of the
flaws in this study is the low number of patients with
long follow-up periods in the popliteal aneurysm
group. However, this is true of all the investigations
into this condition, and reviews suggest that major
vascular centers will only encounter four to five cases
per year.35 Similarly, no data are available regarding
preoperative vein diameter, and it may be that the
patients with popliteal aneurysms had larger long
saphenous veins than did the control population.
However, because obviously varicosed veins would
not have been used for the bypass grafts, the magni-
tude of the relative risk of vein graft aneurysm for-
mation, which is attributable to the presence of
popliteal aneurysm, cannot be explained by this fac-
tor alone. The definition of vein graft aneurysms at
a diameter of 1.5 cm is obviously arbitrary, but it is
interesting to note that if a larger diameter had been
used (eg, 2 cm), only one vein graft aneurysm would
have been shown in the atherosclerotic group.
Traditionally, the autologous vein has been the
preferred conduit for bypass grafting of popliteal
aneurysms. However, the tendency to aneurysm for-
mation may lead to a high incidence rate of revision
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Fig 2. Intraoperative photograph of above-knee true vein graft aneurysm undergoing formal
repair after dilatation to diameter of greater than 3 cm. Both loops surround nondilated vein graft.
surgery, with its attendant risks. Interestingly, Sarcina
et al32 have reported that expanded polytetrafluo-
roethylene and autologous venous conduits have
similar patency rates during popliteal aneurysm
bypass grafting, and they have suggested that
expanded polytetrafluoroethylene be the conduit of
choice. Further studies clearly are necessary to con-
firm these findings, but they do have implications for
the traditional management of popliteal aneurysms in
view of the high rate of degeneration of autologous
venous bypass grafts.
The association between popliteal aneurysms and
vein graft aneurysm formation appears to be shown
strongly in this study. Of all the vascular risk factors
that were analyzed, the presence of arterial aneurys-
mal disease was the only significant predictor of vein
graft dilatation. This has important scientific impli-
cations because the data strongly support the con-
cept of aneurysmal disease as a systemic disorder,
with differing risk factors to atherosclerosis.13 The
idea that the patients with popliteal aneurysms have
a localized manifestation of a dilating diathesis that
affects their veins when implanted into the arterial
circulation is attractive scientifically. Perhaps more
significantly, the findings from this study suggest a
novel approach to the investigation of the cause of
arterial aneurysms. For the first time, a preaneurys-
mal tissue has been identified. The long saphenous
vein from a patient with a popliteal aneurysm has a
40% likelihood of aneurysmal degeneration when
used as a bypass graft conduit as compared with a 2%
chance in the control tissue from patients with
occlusive disease. A biochemical and molecular com-
parison of the long saphenous vein from these two
groups of patients may help elucidate the initiating
factors that are responsible for aneurysmal disease.
The biochemical changes within the wall of the
abdominal aortic aneurysm are well documented,
including the loss of elastin, medial degeneration,
inflammatory infiltration, and increased levels of
matrix metalloproteinase.36 Such changes may be
involved in the aneurysmal change identified in
these vein grafts. However, the number of grafts that
are revised remains small, and we are currently inves-
tigating both the histologic and the biochemical
changes within the long saphenous vein in patients
with aneurysmal and occlusive disease. 
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